RESUMEN
The present study aims to describe state-of-the-art of preclinical studies that have investigated peripheral receptors and neuromediators involved in the antihyperalgesic effects of acupuncture. The PubMed, Scopus, and Web of Science databases were searched using the integrative review method. Preclinical articles that involved the study of peripheral receptors and neuromediators on the pain control effects of acupuncture in rats or mice were selected using a predefined search strategy. From this search, 456 articles were found, and 29 of them met the inclusion criteria of the study. The selected articles addressed the following peripheral receptors: opioid (n = 9), adenosine (n = 5), cannabinoid (n = 5), transient receptor potential vanilloid (TRPV) (n = 3), histamine (n = 2), adrenergic (n = 1), muscarinic (n = 1), corticotrophin-releasing factor (CRF) (n = 2), IL-1 (n = 1), and endothelin (n = 1) receptors. The peripheral neuromediators correlated with the peripheral pain control effect were as follows: opioid peptides (n = 4), adenosine (n = 3), histamine (n = 1), substance P (n = 1) calcitonin gene-related peptide (CGRP) (n = 1), anandamide (n = 1), nitric oxide (n = 1), and norepinephrine (n = 1). This review summarizes the methods used to investigate the peripheral effects of acupuncture and discusses the main findings on each family of receptors and neuromediators. Ten families of peripheral receptors and 8 types of neuromediators were correlated with the antihyperalgesic effects of acupuncture in preclinical studies. Considering the benefits of a better understanding of the role of peripheral receptors and neuromediators in the context pain management, the findings of the present study highlight the importance of deepening the exploration of the peripheral mechanisms of acupuncture.
Asunto(s)
Analgesia por Acupuntura/métodos , Neurotransmisores/metabolismo , Receptores de Neurotransmisores/metabolismo , Analgesia por Acupuntura/efectos adversos , Animales , Humanos , Nocicepción , Receptores Acoplados a Proteínas G/metabolismoRESUMEN
Anxiety disorder is highly prevalent worldwide and represents a chronic and functionally disabling condition, with high levels of psychological stress characterized by cognitive and physiological symptoms. Scopoletin (SP), a main active compound in Angelica dahurica, is traditionally used for the treatment of headache, rhinitis, pain, and other conditions. Here, we evaluated the effects of SP in a mouse model of complete Freund's adjuvant (CFA)-induced chronic inflammation anxiety. SP (2.0, 10.0, 50.0 mg/kg) administration for 2 weeks dose-dependently ameliorated CFA-induced anxiety-like behaviors in the open field test and elevated plus maze test. Moreover, we found that SP treatment inhibited microglia activation and decreased both peripheral and central IL-1ß, IL-6, and TNF-α levels in a dose-dependent manner. Additionally, the imbalance in excitatory/inhibitory receptors and neurotransmitters in the basolateral nucleus after CFA injection was also modulated by SP administration. Our findings indicate that the inhibition of the nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways involving anti-inflammatory activities and regulation of the excitatory/inhibitory balance can be attributed to the anxiolytic effects of SP. Moreover, our molecular docking analyses show that SP also has good affinity for gamma-aminobutyric acid (GABA) transaminase and GABAA receptors. Therefore, these results suggest that SP could be a candidate compound for anxiolytic therapy and for use as a structural base for developing new drugs.
Asunto(s)
Angelica/química , Ansiolíticos/uso terapéutico , Ansiedad/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Agonistas de Receptores de GABA-A/uso terapéutico , Fitoterapia , Escopoletina/uso terapéutico , 4-Aminobutirato Transaminasa/antagonistas & inhibidores , Amígdala del Cerebelo/química , Amígdala del Cerebelo/efectos de los fármacos , Animales , Ansiolíticos/farmacología , Ansiedad/etiología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/farmacología , Prueba de Laberinto Elevado , Adyuvante de Freund/toxicidad , Agonistas de Receptores de GABA-A/farmacología , Inflamación/inducido químicamente , Inflamación/psicología , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Microglía/efectos de los fármacos , Modelos Moleculares , Simulación del Acoplamiento Molecular , FN-kappa B/metabolismo , Neurotransmisores/metabolismo , Prueba de Campo Abierto , Conformación Proteica , Receptores de Neurotransmisores/metabolismo , Escopoletina/farmacologíaRESUMEN
Evidence has shown that neuromedin S (NMS) and its receptor (NMU2R) are expressed in the hypothalamus, pituitary, and testis of pigs. To determine the potential mechanisms of NMS, we systematically investigated the direct effects of NMS on the hypothalamic-pituitary-testicular (HPT) axis of male pigs in vitro. We initially confirmed that NMU2R distributed in isolated hypothalamic cells, anterior pituitary cells and Leydig cells using immunocytochemistry. Subsequently we investigated the direct effects of NMS on hormone secretion from cells (anterior pituitary cells and Leydig cells) treated with different doses of NMS. The results showed that NMS increase the release of LH and FSH from anterior pituitary cells and testosterone from Leydig cells. NMS up-regulated the expression of NMU2R and GnRH mRNAs in hypothalamic cells, NMU2R, LH and FSH mRNAs in anterior pituitary cells, and NMU2R, STAR, P450 and 3ß-HSD mRNAs and the expression of PCNA and Cyclin B1 protein in Leydig cells; moreover, it down-regulated the expression of GnIH mRNA in hypothalamic cells. Using immunofluorescence staining and confocal microscopy, we also demonstrated the colocalization of NMU2R and AR or GnIH in Leydig cells. These data in vitro indicated that NMS may regulate the release and/or synthesis of LH, FSH and testosterone at different levels of the reproductive axis through NMU2R, which provided novel evidence of the potential roles of NMS in regulation of pig reproduction.
Asunto(s)
Hipotálamo/metabolismo , Neuropéptidos/farmacología , Hipófisis/metabolismo , Testículo/metabolismo , Animales , Ciclina B1/metabolismo , Hormona Liberadora de Gonadotropina/metabolismo , Hipotálamo/efectos de los fármacos , Células Intersticiales del Testículo/efectos de los fármacos , Células Intersticiales del Testículo/metabolismo , Masculino , Hipófisis/efectos de los fármacos , Antígeno Nuclear de Célula en Proliferación/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores Androgénicos/metabolismo , Receptores de Neurotransmisores/metabolismo , Porcinos , Testículo/efectos de los fármacos , Testosterona/metabolismoRESUMEN
Since the discovery of chlorpromazine in the 1950's, antipsychotic drugs have been the cornerstone of treatment of schizophrenia, and all attenuate dopamine transmission at the dopamine-2 receptor. Drug development for schizophrenia since that time has led to improvements in side effects and tolerability, and limited improvements in efficacy, with the exception of clozapine. However, the reasons for clozapine's greater efficacy remain unclear, despite the great efforts and resources invested therewith. We performed a comprehensive review of the literature to determine the fate of previously tested, non-dopamine-2 receptor experimental treatments. Overall we included 250 studies in the review from the period 1970 to 2017 including treatments with glutamatergic, serotonergic, cholinergic, neuropeptidergic, hormone-based, dopaminergic, metabolic, vitamin/naturopathic, histaminergic, infection/inflammation-based, and miscellaneous mechanisms. Despite there being several promising targets, such as allosteric modulation of the NMDA and α7 nicotinic receptors, we cannot confidently state that any of the mechanistically novel experimental treatments covered in this review are definitely effective for the treatment of schizophrenia and ready for clinical use. We discuss potential reasons for the relative lack of progress in developing non-dopamine-2 receptor treatments for schizophrenia and provide recommendations for future efforts pursuing novel drug development for schizophrenia.
Asunto(s)
Antipsicóticos/uso terapéutico , Neurotransmisores/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Antipsicóticos/efectos adversos , Antipsicóticos/farmacología , Ensayos Clínicos como Asunto , Humanos , Neurotransmisores/efectos adversos , Neurotransmisores/farmacología , Trastornos Psicóticos/tratamiento farmacológico , Trastornos Psicóticos/metabolismo , Receptores de Neurotransmisores/metabolismo , Esquizofrenia/metabolismoRESUMEN
This study investigated the role of γ-aminobutyric acid subtype B (GABAB) receptors in tibial and pudendal neuromodulation of bladder overactivity induced by intravesical administration of dilute (0.5%) acetic acid (AA) in α-chloralose-anesthetized cats. To inhibit bladder overactivity, tibial or pudendal nerve stimulation (TNS or PNS) was applied at 5 Hz and two or four times threshold (T) intensity for inducing toe or anal sphincter twitch. TNS at 2T or 4T intensity significantly (P < 0.05) increased the bladder capacity to 173.8 ± 16.2 or 198.5 ± 24.1%, respectively, of control capacity. Meanwhile, PNS at 2T or 4T intensity significantly (P < 0.05) increased the bladder capacity to 217 ± 18.8 and 221.3 ± 22.3% of control capacity, respectively. CGP52432 (a GABAB receptor antagonist) at intravenous dosages of 0.1-1 mg/kg completely removed the TNS inhibition in female cats but had no effect in male cats. CGP52432 administered intravenously also had no effect on control bladder capacity or the pudendal inhibition of bladder overactivity. These results reveal a sex difference in the role of GABAB receptors in tibial neuromodulation of bladder overactivity in cats and that GABAB receptors are not involved in either pudendal neuromodulation or irritation-induced bladder overactivity.
Asunto(s)
Terapia por Estimulación Eléctrica/métodos , Receptores de GABA-B/metabolismo , Nervio Tibial/fisiopatología , Vejiga Urinaria Hiperactiva/prevención & control , Vejiga Urinaria Hiperactiva/fisiopatología , Vejiga Urinaria/fisiopatología , Animales , Gatos , Femenino , Masculino , Nervio Pudendo/fisiología , Receptores de Neurotransmisores/metabolismo , Caracteres Sexuales , Resultado del Tratamiento , Vejiga Urinaria/inervaciónRESUMEN
Albiflorin, a traditional Chinese herb, is a main component of Radix paeoniae Alba, which has been used for the treatment of depressive disorders since ancient times. However, the mechanism of the antidepressant effect of albiflorin is poorly understood. Thus, we explored the binding profile of albiflorin at neurotransmitter receptors and transporters. We also characterised the in vivo effect of albiflorin on monoaminergic systems by using microanalysis to determine the extracellular levels of serotonin (5-HT) and norepinephrine (NE) in the hypothalamus of freely moving rats administered albiflorin. We found that albiflorin inhibited the uptake of 5-HT and NE and displayed robust binding affinities for the transporters of both neurotransmitters. By contrast, albiflorin (10 µM) showed no significant affinity to a wide array of central nervous system receptors. The results of our in vivo microdialysis studies showed that administration of albiflorin (3.5, 7.0, 14.0 mg/kg) significantly increased extracellular concentrations of 5-HT and NE in the hypothalamus of freely moving rats. Overall, the current study showed that albiflorin is a novel 5-HT and NE reuptake inhibitor with high selectivity.
Asunto(s)
Hidrocarburos Aromáticos con Puentes/farmacología , Hipotálamo/metabolismo , Proteínas de Transporte de Neurotransmisores/metabolismo , Norepinefrina/metabolismo , Paeonia/química , Receptores de Neurotransmisores/metabolismo , Serotonina/metabolismo , Animales , Hidrocarburos Aromáticos con Puentes/química , Masculino , Ratas , Ratas Sprague-DawleyRESUMEN
Fatty acid sensitive neurons located in hypothalamus, hippocampus or striatum are able to detect daily variations of plasma fatty acid levels. Thus, these neurons play a role to regulate energy balance by controling food intake, insulin secretion or hepatic glucose production. Molecular mechanisms that mediate fatty acid effects include receptor FAT (fatty acid transporter)/CD36. Deregulation of this brain lipid sensing may be an early event leading to further dysfunction of energy balance leading to obesity and type 2 diabetes.
Asunto(s)
Encéfalo/metabolismo , Metabolismo Energético , Metabolismo de los Lípidos/fisiología , Animales , Ácidos Grasos/metabolismo , Humanos , Hipotálamo/metabolismo , Neuronas/metabolismo , Neurotransmisores/metabolismo , Receptores de Neurotransmisores/metabolismoRESUMEN
Prior to the designation of illegal drugs (psychoactive drugs) by prefectural regulations, the Tokyo Metropolitan Government conducts surveys on the risk of drugs, reports the results to the governor through the Tokyo Metropolitan Government Advisory Committee on Illegal Drugs, an affiliated organization, and provides the central government with information. The Tokyo Metropolitan Institute of Public Health conducts identification of the constituents of drugs and biological effect tests to help the committee analyze and assess information on the risks of drugs. Narcotics and stimulants increase the concentrations of dopamine, serotonin, and norepinephrine, i.e., neurotransmitters, in the presynaptic clefts, exerting an excitatory effect. In the postsynaptic region, these neurotransmitters are considered to directly combine with the receptors and activate guanine nucleotide-binding proteins, causing activation. We have developed nine types (categorized into three groups) of simple, high-throughput measurement systems and examined their measurement methods. The systems are designed to assess the following properties of drugs: effects of: 1) inhibiting reuptake; 2) stimulating the release of neurotransmitters in the presynaptic region; and 3) activating G proteins in the postsynaptic region. The systems provide useful information in that they allow searches for the effects of a variety of psychoactive substances that are expected to become widespread, e.g., designer drugs, hallucinogenic plants and synthetic cannabinoids; they also allow you to conduct a test using micrograms of a drug, facilitating testing even when it is not available in a large quantity.
Asunto(s)
Drogas de Diseño , Evaluación Preclínica de Medicamentos/métodos , Control de Medicamentos y Narcóticos , Drogas Ilícitas , Psicotrópicos/efectos adversos , Psicotrópicos/farmacología , Animales , Proteínas de Unión al GTP/metabolismo , Agencias Gubernamentales , Humanos , Neurotransmisores/metabolismo , Unión Proteica , Psicotrópicos/química , Psicotrópicos/metabolismo , Receptores de Neurotransmisores/metabolismo , Serotonina/metabolismo , Trastornos Relacionados con Sustancias/prevención & control , Sinapsis/metabolismo , TokioRESUMEN
In this study, we investigated genetic mechanisms of neurotransmitters in regulating the formation of adverse effects on locomotion behavior in Al2O3 nanoparticles (NPs)-exposed Caenorhabditis elegans. Al2O3-NPs exposure caused the decrease of locomotion behavior with head thrash and body bend as endpoints. Interestingly, the neurotransmitters of glutamate, serotonin, and dopamine were required for the adverse effects of Al2O3-NPs on locomotion behavior in nematodes. Glutamate transporter EAT-4, serotonin transporter MOD-5, and dopamine transporter DAT-1 might serve as the molecular targets of Al2O3-NPs for neurotoxicity formation. Moreover, the behavioral response of nematodes to Al2O3-NPs exposure was primarily mediated by non-NMDA glutamate receptors GLR-2 and GLR-6, ionotropic serotonin receptor MOD-1, and D1-like dopamine receptor DOP-1. Therefore, Al2O3-NPs exposure influences locomotion behavior of nematodes primarily by impinging on their glutamatergic, serotoninergic, and dopaminergic systems. Our data will shed light on questions surrounding the involvement of neurotransmitters in mediating the adverse behavioral effects from Al2O3-NPs.
Asunto(s)
Óxido de Aluminio/toxicidad , Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/metabolismo , Dopamina/metabolismo , Ácido Glutámico/metabolismo , Nanopartículas/toxicidad , Serotonina/metabolismo , Análisis de Varianza , Animales , Conducta Animal/efectos de los fármacos , Dopamina/genética , Ácido Glutámico/genética , Locomoción/efectos de los fármacos , Neurotoxinas/toxicidad , Neurotransmisores/genética , Neurotransmisores/metabolismo , Receptores de Neurotransmisores/metabolismo , Serotonina/genéticaRESUMEN
Neuromedin U (NMU) is a structurally highly conserved neuropeptide and has been paired with the G-protein-coupled receptors (GPCRs) NMUR1 and NMUR2, which were formerly classified in the orphan receptor family. Activation of the G protein Gq/11 subunit causes a pertussis toxin (PTX)-insensitive activation of both phospholipase C and mitogen-activated protein kinase (MAP), and activation of the Go subunit causes a PTX-sensitive inhibition of adenyl cyclase. Additionally, NMU selectively inhibits L-type high-voltage-gated Ca2+ channels in mouse hippocampus, as well as low-voltage-activated T-type Ca2+ channels in mouse dorsal root ganglia (DRG). NMU peptide and its receptors are predominantly expressed in the gastrointestinal tract and specific structures within the brain, reflecting its major role in the regulation of energy homeostasis. A novel neuropeptide, neuromedin S (NMS), is structurally related to NMU. They share a C-terminal core structure and both have been implicated in the regulation of food intake, as well as the circadian rhythms. The acute anorectic and weight-reducing effects of NMU and NMS are mediated by NMUR2. This suggests that NMUR2-selective agonists may be useful for the treatment of obesity.
Asunto(s)
Canales de Calcio Tipo L/efectos de los fármacos , Ingestión de Alimentos/efectos de los fármacos , Metabolismo Energético/efectos de los fármacos , Metabolismo Energético/fisiología , Homeostasis/fisiología , Neuropéptidos/metabolismo , Receptores de Neurotransmisores/antagonistas & inhibidores , Animales , Ritmo Circadiano/fisiología , Ingestión de Alimentos/fisiología , Subunidades alfa de la Proteína de Unión al GTP Gq-G11/metabolismo , Ganglios Espinales/efectos de los fármacos , Ganglios Espinales/metabolismo , Homeostasis/efectos de los fármacos , Humanos , Hipotálamo/efectos de los fármacos , Hipotálamo/metabolismo , Ratones , Proteínas Quinasas Activadas por Mitógenos/metabolismo , Neuropéptidos/agonistas , Neuropéptidos/química , Obesidad/tratamiento farmacológico , Receptores de Neurotransmisores/metabolismo , Fosfolipasas de Tipo C/metabolismo , Pérdida de PesoRESUMEN
In seasonal mammals, growth, energy balance, and reproductive status are regulated by the neuroendocrine effects of photoperiod. Thyroid hormone (TH) is a key player in this response in a number of species. A neuroendocrine role for the nutritional factor vitamin A has not been considered, although its metabolic product retinoic acid (RA) regulates transcription via the same nuclear receptor family as TH. We hypothesized that vitamin A/RA plays a role in the neuroendocrine hypothalamus alongside TH signaling. Using a reporter assay to measure RA activity, we demonstrate that RA activity levels in the hypothalamus of photoperiod-sensitive F344 rats are reduced in short-day relative to long-day conditions. These lower RA activity levels can be explained by reduced expression of a whole network of RA signaling genes in the ependymal cells around the third ventricle and in the arcuate nucleus of the hypothalamus. These include genes required for uptake (Ttr, Stra6, and Crbp1), synthesis (Raldh1), receptor response (RAR), and ligand clearance (Crapb1 and Cyp26B1). Using melatonin injections into long-day rats, we show that the probable trigger of the fall in RA is melatonin. Surprisingly we also found RPE65 expression in the mammalian hypothalamus for the first time. Similar to RA signaling genes, members of the Wnt/ß-catenin pathway and NMU and its receptor NMUR2 are also under photoperiodic control. Our data provide strong evidence for a novel endocrine axis, involving the nutrient vitamin A regulated by photoperiod and melatonin and suggest a role for several new players in the photoperiodic neuroendocrine response.
Asunto(s)
Fotoperiodo , Vitamina A/metabolismo , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Animales , Regulación de la Expresión Génica/fisiología , Hipotálamo/fisiología , Masculino , Melatonina/farmacología , Neuropéptidos/genética , Neuropéptidos/metabolismo , Ratas , Ratas Endogámicas F344 , Receptores de Neurotransmisores/genética , Receptores de Neurotransmisores/metabolismo , Transducción de Señal/fisiología , Transducción de Señal/efectos de la radiación , Proteínas Wnt/genética , beta Catenina/genéticaRESUMEN
OBJECTIVE: To screen out active substances on Neuromedin U2 receptor (NMU2R) by using stable NMU2R cell lines and negative cell lines and analyzing siRNA interference. METHOD: NMU2R cells were used to observe the activating effect of nine nine citrus flavonoids on NMU2R cell. Afterwards, false-positive interference of citrus flavonoids that showed higher activating effect was eliminated by using negative cells and analyzing the efficiency of siRNA interference. RESULT: Hesperidin and nobiletin contained in citrus flavonoids were found to effectively activate NMU2R. The efficacy, EC50 and potency values of hesperidin were 4.688, 318.970 micromol x L(-1) and 200.933 micromol x L(-1), while the efficacy, EC50 and potency values of nobiletin were 4.758, 5.832 micromol x L(-1) and 3.124 micromol x L(-). CONCLUSION: Hesperidin and nobiletin contained in citrus flavonoids can activate NMU2R. Nobiletin shows such a low EC50 that it has medicinal value.
Asunto(s)
Citrus/química , Flavonoides/farmacología , Extractos Vegetales/farmacología , Interferencia de ARN/efectos de los fármacos , ARN Interferente Pequeño/genética , Receptores de Neurotransmisores/genética , Línea Celular , Expresión Génica/efectos de los fármacos , Humanos , ARN Interferente Pequeño/metabolismo , Receptores de Neurotransmisores/metabolismoRESUMEN
Neuromedin S (NMS) has been found to be involved in the regulation of the reproductive, endocrine, and immune systems in mammals. However, its function in pigs is currently not well understood. Thus, it is essential and important to characterize the central distribution of NMS mRNA and its receptor, neuromedin U receptor-2 (NMU2R), in pigs for clarifying its physiological functions. In this study, we found that NMS mRNA were densely distributed in the hypothalamus, hypophysis, hippocampus, and brain stem of pigs by in situ hybridization. Moreover, NMS and NMU2R mRNAs was also expressed in the alimentary organs, endocrine and lymphatic organs, and ovaries by semi-Q RT-PCR. All these results suggest that the NMS/NMU2R system plays an important role in modulating various physiological functions in pigs. This research provides useful information for predicting the physiological functions of the NMS/NMU2R system in pigs.
Asunto(s)
Neuropéptidos/metabolismo , Receptores de Neurotransmisores/metabolismo , Animales , Química Encefálica , Tronco Encefálico/química , Femenino , Hipocampo/química , Hipotálamo/química , Hibridación in Situ/veterinaria , Neuropéptidos/análisis , Neuropéptidos/fisiología , Receptores de Neurotransmisores/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa/veterinaria , Porcinos/metabolismo , Porcinos/fisiología , Distribución TisularRESUMEN
Atopic dermatitis is a chronic inflammatory skin disease characterized by impaired epidermal barrier function, inflammatory infiltration, extensive pruritus and a clinical course defined by symptomatic flares and remissions. The mechanisms of disease exacerbation are still poorly understood. Clinical occurrence of atopic dermatitis is often associated with psychological stress. In response to stress, upregulation of neuropeptide mediators in the brain, endocrine organs, and peripheral nervous system directly affect immune and resident cells in the skin. Lesional and non-lesional skin of patients with atopic dermatitis demonstrates increased mast cells and mast cell-nerve fiber contacts. In the setting of stress, sensory nerves release neuromediators that regulate inflammatory and immune responses, as well as barrier function. Progress towards elucidating these neuroimmune connections will refine our understanding of how emotional stress influences atopic dermatitis. Moreover, psychopharmacologic agents that modulate neuronal receptors or the amplification circuits of inflammation are attractive options for the treatment of not only atopic dermatitis, but also other stress-mediated inflammatory skin diseases.
Asunto(s)
Dermatitis Atópica/inmunología , Dermatitis Atópica/psicología , Neuroinmunomodulación , Estrés Psicológico/inmunología , Citocinas/metabolismo , Dermatitis Atópica/metabolismo , Dermatitis Atópica/fisiopatología , Humanos , Sistema Hipotálamo-Hipofisario/metabolismo , Mastocitos , Sistema Hipófiso-Suprarrenal/metabolismo , Receptores de Neurotransmisores/metabolismo , Estrés Psicológico/metabolismo , Linfocitos TRESUMEN
Following on our discovery that pulp and paper mill effluents can interact with, and disrupt, various neurotransmitter receptors and enzymes important to fish reproduction, we tested wood and bark extracts of 14 Eastern North American hardwood trees used in pulp and paper production. Radioligand binding to neurotransmitter receptors, including the dopamine-2 receptor (D2), the gamma aminobutyric acid receptor A (GABA(A)), N-methyl-D-aspartic acid (NMDA) receptor, and muscarinic cholinergic receptor (mACh-R), were significantly changed following in vitro incubations with many but not all extracts. Activities of neurotransmitter-related enzymes monoamine oxidase (MAO), GABA-transaminase (GABA-T), acetylcholinesterase (AChE) and glutamic acid decarboxylase (GAD) were also significantly altered. Butternut wood extracts and the isolated compound juglone significantly inhibited the enzymatic activities of MAO and GAD which we suggest may be part of a mechanism that may negatively affect fish reproduction. Besides giving credence to the hypothesis that neuroactive compounds in pulp and paper effluent may originate in the trees used by mills, the results reported here also indicate important neuropharmacological activities in hardwoods which may help identify new sources of biologically active natural products.
Asunto(s)
Encéfalo/metabolismo , Naftoquinonas/farmacología , Corteza de la Planta/química , Extractos Vegetales/farmacología , Receptores de Neurotransmisores/metabolismo , Árboles/química , Madera/química , Acetilcolinesterasa/metabolismo , Análisis de Varianza , Animales , Encéfalo/efectos de los fármacos , Glutamato Descarboxilasa/metabolismo , Carpa Dorada , Monoaminooxidasa/metabolismo , Naftoquinonas/análisis , América del Norte , Papel , Ensayo de Unión Radioligante , Receptores de Dopamina D2/metabolismo , Receptores de GABA-A/metabolismo , Receptores Muscarínicos/metabolismo , Receptores de N-Metil-D-Aspartato/metabolismo , Transaminasas/metabolismoRESUMEN
OBJECTIVE: To observe the effects of early intervention with effective components from a Chinese herbal formula (Huannao Yicong formula, HNYCF) on behavior and related indicators of cholinergic system in ß-amyloid precursor protein (APP) transgenic mice. METHODS: Sixty 3-month-old APP695 V717I transgenic mice were randomly divided into model group, high-dose HNYCF group (2.80 g/(kg·d)), low-dose HNYCF group (1.40 g/(kg·d)) and donepezil group (0.65 mg/(kg·d)), with 15 mice in each group. Fifteen non-transgenic mice of the same genetic background were used as normal group. The model group and normal group were fed with equal volume of distilled water by gavage. After 6-month continuous medication, the Morris water maze and the passive avoidance test were used to detect the visual spatial learning and memory ability of each mouse. Then the mice were decapitated and their cerebral cortex and hippocampus were isolated to homogenate by sonication. Contents of acetylcholine (ACh) and acetylcholinesterase (AChE) and choline acetyltransferase (ChAT) activity in the homogenate were determined by enzyme-linked immunosorbent assay, and protein contents of cerebral cortex and hippocampus were measured by Coomassie brilliant blue method. RESULTS: Compared with the model group, high- and low-dose HNYCF and donepezil hydrochloride all improved spatial learning of APP mice in the Morris water maze. The ratio of swimming distance in the central area in the high-dose HNYCF group was longer than that in the model group (P<0.05). In the passive avoidance test, high- and low-dose HNYCF and donepezil hydrochloride improved memory function of APP mice by improving the escape latency and reducing the number of errors (P<0.05, P<0.01). High- and low-dose HNYCF and donepezil hydrochloride reduced the content of AChE, increased the activity of ChAT (P<0.01, P<0.05) and improved the content of ACh in hippocampus (P<0.05); high- and low-dose HNYCF and donepezil hydrochloride increased the content of ACh in cortex (P<0.05). Donepezil hydrochloride reduced the content of AChE in cortex (P<0.05), however, high- and low-dose HNYCF had no obvious influence (P>0.05). High- and low-dose HNYCF increased the content of ChAT in cortex (P<0.05), whereas donepezil hydrochloride had no obvious influence (P>0.05). CONCLUSION: Early intervention with HNYCF effective components can improve the learning and memory ability of APP transgenic mice. The mechanism may be related to enhancing the function of cholinergic system.
Asunto(s)
Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/fisiopatología , Conducta Animal , Colinérgicos/farmacología , Medicamentos Herbarios Chinos/farmacología , Enfermedad de Alzheimer/genética , Precursor de Proteína beta-Amiloide/genética , Animales , Modelos Animales de Enfermedad , Donepezilo , Intervención Médica Temprana , Femenino , Indanos/farmacología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Memoria/efectos de los fármacos , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Nootrópicos/farmacología , Piperidinas/farmacología , Receptores de Neurotransmisores/metabolismoRESUMEN
ETHNOPHARMACOLOGICAL RELEVANCE: Amazonian peoples utilize a variety of psychoactive plants that may contain novel biologically active compounds. Efforts to investigate such remedies in terms of neuropharmacology have been limited. AIM OF THIS STUDY: This study identified Amazonian ethnomedicines with potential for the treatment of cognitive deficits in schizophrenia and dementias, and characterized their interactions with CNS neurotransmitter receptors in vitro. MATERIALS AND METHODS: Approximately 300 Amazonian species with folk uses or constituents indicative of central nervous system activity were incorporated into a database constructed from literature searches, herbarium surveys, and interviews with traditional practitioners. Approximately 130 of these targeted species were collected in Loreto province, Peru, and 228 fractions derived from them were screened in 31 radioreceptor assays via the resources of the NIMH Psychoactive Drug Screening Program. A subset was also screened in functional assays at selected serotonin, muscarinic, and adrenergic receptors. RESULTS: Ninety-one samples displayed ≥60% inhibition of radioligand binding activity in receptor assays; 135 samples displayed agonist or antagonist activity (or both) in functional assays. CONCLUSIONS: Potential CNS activity was detected in about 40% of the samples screened, with some correlations to both folk uses and phytochemical constituents. These results may point to novel and potentially therapeutic CNS active compounds.
Asunto(s)
Trastornos del Conocimiento/tratamiento farmacológico , Descubrimiento de Drogas/métodos , Medicina Tradicional , Neurotransmisores/farmacología , Fitoterapia , Extractos Vegetales/farmacología , Plantas Medicinales , Trastornos del Conocimiento/metabolismo , Demencia/tratamiento farmacológico , Etnofarmacología/métodos , Humanos , Entrevistas como Asunto , Neurotransmisores/uso terapéutico , Perú , Extractos Vegetales/uso terapéutico , Psicotrópicos/farmacología , Psicotrópicos/uso terapéutico , Receptores de Neurotransmisores/metabolismo , Esquizofrenia/tratamiento farmacológicoRESUMEN
Intracerebroventricular administration of neuromedin U (NMU) exerts an anorexigenic effect in a goldfish model. However, little is known about the NMU receptor and its signalling system in fish. In the present study, we isolated and cloned two cDNAs encoding different proteins comprising 429 and 388 amino acid residues from the goldfish brain based on the nucleotide sequences of human NMU receptor 1 (NMU-R1) and receptor 2 (NMU-R2). Hydropathy and phylogenetic analyses suggested that these two proteins were orthologues of NMU-R1 and -R2 of goldfish. We established two human embryonic kidney 293 cell lines stably expressing putative NMU-R1 and -R2, respectively, and showed that NMU induced an increase in intracellular calcium concentration ([Ca(2+)](i)) in these cells. We examined the presence of NMU-R1 and -R2 in the goldfish brain by western blotting analysis using affinity-purified antisera raised against peptide fragments derived from these receptors. NMU-R1-specific and NMU-R2-specific antisera detected a 49-kDa and 45-kDa immunopositive bands, respectively, in the brain extract. The mass of each band corresponded to that of the deduced respective primary structures. Reverse transcriptase-polymerase chain reaction analysis showed that NMU-R1 and -R2 transcripts were detected in several tissues. In particular, both mRNAs were strongly expressed in the goldfish brain. By contrast, NMU-R2 mRNA was also expressed in the gut. These results indicate for the first time that NMU-R orthologues exist in goldfish, and suggest physiological roles of NMU and its receptor system in fish.
Asunto(s)
Encéfalo/metabolismo , Carpa Dorada/genética , Receptores de Neurotransmisores/genética , Secuencia de Aminoácidos , Animales , Calcio/farmacocinética , Células Cultivadas , Clonación Molecular , ADN Complementario/análisis , ADN Complementario/aislamiento & purificación , Femenino , Carpa Dorada/metabolismo , Humanos , Masculino , Datos de Secuencia Molecular , Fragmentos de Péptidos/farmacología , Filogenia , Receptores de Neurotransmisores/química , Receptores de Neurotransmisores/metabolismo , Receptores de Neurotransmisores/fisiología , Homología de Secuencia de Aminoácido , Distribución TisularRESUMEN
Neurosteroids, such as pregnenolone (PREG), dehydroepiandrosterone (DHEA), and their sulfates (PREGS and DHEAS) are reported to have a modulatory effect on neuronal excitability and synaptic plasticity. They also have many other functions associated with neuroprotection, response to stress, mood regulation, and cognitive performance. Furthermore, these neurosteroids have been linked to, and their levels are altered in, neuropsychiatric disorders. This review highlights what is currently known about the metabolism and mode of action of PREG and DHEA, as well as about alterations of these neurosteroids in schizophrenia. This review also provides substantial information about clinical trials with DHEA and PREG augmentation with of antipsychotic agents in schizophrenia.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Deshidroepiandrosterona/uso terapéutico , Pregnenolona/uso terapéutico , Esquizofrenia/tratamiento farmacológico , Adyuvantes Inmunológicos/metabolismo , Adyuvantes Inmunológicos/farmacología , Animales , Antipsicóticos/farmacología , Antipsicóticos/uso terapéutico , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/metabolismo , Ensayos Clínicos como Asunto , Deshidroepiandrosterona/metabolismo , Deshidroepiandrosterona/farmacología , Humanos , Fármacos Neuroprotectores/farmacología , Fármacos Neuroprotectores/uso terapéutico , Pregnenolona/metabolismo , Pregnenolona/farmacología , Receptores de Neurotransmisores/metabolismo , Esquizofrenia/fisiopatologíaRESUMEN
A Chlorella powder was tested in a total of 129 in vitro receptor binding assay systems. The results showed a potent inhibition of this powder on cysteinyl leukotriene CysLT2, and glutamate AMPA in a dose-concentration manner with IC(50) mean +/- SEM values of 20 +/- 4.5 microg/mL and 44 +/- 14 microg/mL, respectively. Other moderate and weak activities reflected in competitive binding experiments were seen versus adenosine transporter; calcium channel L-type, benzothiazepine; gabapentin; kainate, NMDA-glycine; inositol trisphosphate IP(3); cysteinyl CysLT(1), LTB(4); purinergic P(2Y); tachykinin NK(2); serotonin 5-HT(2B) and prostanoid, thromboxane A(2). Together, the results suggest that the various inhibitory effects of Chlorella powder in these receptor binding assays could reflect its actions in modulating Ca(2+)-dependent signal related targets and might be relevant to the mechanisms of its biological effects. These results reveal important potential biochemical activities that might be exploited for the prevention or treatment of several pathologies. From these results, the possible therapeutic usage of the product is discussed.